Engineers Gate Manager LP Pacira Bio Sciences, Inc. Transaction History

Engineers Gate Manager LP

$8.12 Billion
Q3 2025

A detailed history of Engineers Gate Manager LP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 47,810 shares of PCRX stock, worth $1.14 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

47,810

Previous 79,961 40.21%

Holding current value

$1.14 Million

Previous $1.91 Million 35.53%

% of portfolio

0.02%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$21.09 - $27.22 $678,064 - $875,150	-32,151 Reduced 40.21%	47,810 $1.23 Million
Q2 2025 Aug 14, 2025	BUY	$22.91 - $27.14 $819,719 - $971,069	35,780 Added 80.99%	79,961 $1.91 Million
Q1 2025 May 15, 2025	SELL	$18.33 - $27.25 $827,929 - $1.23 Million	-45,168 Reduced 50.55%	44,181 $1.1 Million
Q4 2024 Feb 14, 2025	BUY	$15.3 - $20.33 $1.16 Million - $1.54 Million	75,804 Added 559.65%	89,349 $1.68 Million
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $17,222 - $41,893	1,472 Added 12.19%	13,545 $203,000

Q2 2024 Aug 14, 2024	SELL	$25.5 - $31.51 $186,558 - $230,527	-7,316 Reduced 37.73%	12,073 $345,000
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $537,075 - $687,921	19,389 New	19,389 $566,000
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $285,139 - $372,596	9,294 New	9,294 $285,000
Q1 2023 May 15, 2023	SELL	$35.53 - $43.38 $1.26 Million - $1.54 Million	-35,406 Reduced 67.96%	16,693 $681,000
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $1.99 Million - $2.99 Million	52,099 New	52,099 $2.01 Million
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $929,426 - $1.04 Million	-17,010 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $44,385 - $52,492	750 Added 4.61%	17,010 $1.03 Million
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $700,984 - $931,573	11,819 Added 266.13%	16,260 $1.14 Million
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $9,084 - $11,926	180 Added 4.22%	4,441 $266,000
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $221,444 - $268,443	4,261 New	4,261 $256,000
Q2 2020 Aug 17, 2020	SELL	$30.8 - $52.47 $1.39 Million - $2.38 Million	-45,266 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $616,251 - $1.1 Million	-21,699 Reduced 32.4%	45,266 $1.52 Million
Q4 2019 Feb 14, 2020	BUY	$36.31 - $46.83 $2.43 Million - $3.14 Million	66,965 New	66,965 $3.03 Million
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $2.74 Million - $3.46 Million	-76,881 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $374,769 - $491,596	-10,248 Reduced 11.76%	76,881 $3.34 Million
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $901,210 - $1.04 Million	24,711 Added 39.59%	87,129 $3.32 Million
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $385,628 - $486,913	-9,335 Reduced 13.01%	62,418 $2.69 Million
Q3 2018 Nov 01, 2018	BUY	$32.85 - $52.0 $352,611 - $558,168	10,734 Added 17.59%	71,753 $3.53 Million
Q2 2018 Aug 03, 2018	BUY	$27.5 - $39.8 $1.68 Million - $2.43 Million	61,019 New	61,019 $1.96 Million

Others Institutions Holding PCRX

# of Institutions

260

Shares Held

48.9M

Call Options Held

118K

Put Options Held

63.7K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.09B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Pacira Bio Sciences, Inc. Transaction History